- Home
- CTSO vs FLNT Comparison
CTSO vs FLNT Comparison
Compare CTSO & FLNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CTSO
- FLNT
- Stock Information
- Founded
- CTSO 1997
- FLNT 2010
- Country
- CTSO United States
- FLNT United States
- Employees
- CTSO N/A
- FLNT N/A
- Industry
- CTSO Medical/Dental Instruments
- FLNT Advertising
- Sector
- CTSO Health Care
- FLNT Consumer Discretionary
- Exchange
- CTSO Nasdaq
- FLNT Nasdaq
- Market Cap
- CTSO 61.3M
- FLNT 58.9M
- IPO Year
- CTSO N/A
- FLNT N/A
- Fundamental
- Price
- CTSO $1.00
- FLNT $2.21
- Analyst Decision
- CTSO Strong Buy
- FLNT Hold
- Analyst Count
- CTSO 3
- FLNT 1
- Target Price
- CTSO $4.67
- FLNT $3.50
- AVG Volume (30 Days)
- CTSO 83.4K
- FLNT 13.1K
- Earning Date
- CTSO 05-08-2025
- FLNT 04-04-2025
- Dividend Yield
- CTSO N/A
- FLNT N/A
- EPS Growth
- CTSO N/A
- FLNT N/A
- EPS
- CTSO N/A
- FLNT N/A
- Revenue
- CTSO $37,739,531.00
- FLNT $254,623,000.00
- Revenue This Year
- CTSO $9.20
- FLNT $11.65
- Revenue Next Year
- CTSO $11.64
- FLNT $6.29
- P/E Ratio
- CTSO N/A
- FLNT N/A
- Revenue Growth
- CTSO 1.80
- FLNT N/A
- 52 Week Low
- CTSO $0.70
- FLNT $2.01
- 52 Week High
- CTSO $1.61
- FLNT $4.30
- Technical
- Relative Strength Index (RSI)
- CTSO 44.00
- FLNT 41.05
- Support Level
- CTSO $0.97
- FLNT $2.01
- Resistance Level
- CTSO $1.08
- FLNT $2.33
- Average True Range (ATR)
- CTSO 0.07
- FLNT 0.16
- MACD
- CTSO -0.01
- FLNT 0.02
- Stochastic Oscillator
- CTSO 17.53
- FLNT 31.25
About CTSO Cytosorbents Corporation
CytoSorbents Corp specializes in treating life-threatening conditions in intensive care and cardiac surgery using proprietary polymer adsorption technology. Its flagship product, CytoSorb, is approved in the EU as an extracorporeal cytokine absorber, aiming to reduce inflammation and prevent multiple organ failure in critical illnesses like sepsis and trauma. Revenue primarily comes from product sales in Germany, with additional income from grant agencies in the United States. The company operates through Direct sales, Distributors/strategic partners, and Government segments. The company's product consists of Cytosorb, ECOS-300CY, VetResQ, HemoDefend, and DrugSorb-ATR.
About FLNT Fluent Inc.
Fluent Inc is a data-driven digital marketing services company. It performs customer acquisition services by operating digital marketing campaigns, through which it connects its advertiser clients with consumers they are seeking to reach. It delivers data and performance-based marketing executions to its clients, such as consumer brands, direct marketers and agencies across a wide range of industries, including Financial Products & Services, Media & Entertainment, Health & Wellness, Staffing & Recruitment and Retail & Consumer.